股本结构
单位：万股
| 公告日期 | 2025-11-07 | 2025-08-08 | 2025-08-08 | 2025-05-14 | 2025-04-04 | 2025-05-14 |
|---|---|---|---|---|---|---|
| 证券总股本 | 729.91 | 723.96 | 437.78 | 437.78 | 364.34 | 337.34 |
| 普通股本 | 729.91 | 723.96 | 437.78 | 437.78 | 364.34 | 337.34 |
| 优先股 | 25.00 | 未披露 | 25.00 | 未披露 | 未披露 | 25.00 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-09-30 | 2025-08-06 | 2025-06-30 | 2025-05-13 | 2025-04-03 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-07 | 729.91 | 25.00 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common shares, equity fee on At-the-Market and equity offerings
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
|
2025-09-30 |
| 2025-08-08 | 723.96 | 未披露 | 定期报告 | 2025-08-06 |
| 2025-08-08 | 437.78 | 25.00 |
更多>>
From March 31, 2025 to June 30, 2025
Stock-based compensation expenses
Exercise of warrants
|
2025-06-30 |
| 2025-05-14 | 437.78 | 未披露 | 定期报告 | 2025-05-13 |
| 2025-04-04 | 364.34 | 未披露 | 定期报告 | 2025-04-03 |
| 2025-05-14 | 337.34 | 25.00 |
更多>>
From December 31, 2024 to March 31, 2025
Issuance of common shares - Annual Stock Dividend
Issuance of common shares, equity fee on At-the-Market and equity offerings
Issuance of common shares, net of offering costs - Equity Offerings
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Abeyance Shares released
Exercise of warrants
Reverse Split (1-for-50) adjustment
|
2025-03-31 |
| 2025-03-28 | 330.56 | 未披露 | 定期报告 | 2025-03-26 |
| 2025-03-03 | 275.55 | 25.00 | 定期报告 | 2025-02-19 |
| 2025-02-07 | 263.57 | 未披露 |
更多>>
Securities offering 495,000 shares of common stock by the company
|
2025-02-07 |
| 2025-02-05 | 214.07 | 未披露 | 定期报告 | 2025-01-31 |
| 2025-01-15 | 214.54 | 未披露 |
更多>>
a 1-for-50 reverse stock split of its issued and outstanding common stock
|
2025-01-16 |
| 2025-01-15 | 6564.54 | 未披露 | 定期报告 | 2025-01-14 |
| 2025-01-15 | 6476.88 | 未披露 | 定期报告 | 2025-01-10 |
| 2024-12-06 | 4961.42 | 25.00 | 定期报告 | 2024-12-04 |
| 2024-11-22 | 4693.49 | 未披露 | 定期报告 | 2024-11-15 |
| 2024-11-08 | 4778.02 | 未披露 | 定期报告 | 2024-11-07 |
| 2025-01-22 | 4190.57 | 未披露 | 定期报告 | 2024-10-24 |
| 2024-11-08 | 3767.31 | 25.00 |
更多>>
From June 30, 2024 to September 30, 2024
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Stock-based compensation expenses
|
2024-09-30 |
| 2024-08-13 | 3723.26 | 未披露 | 定期报告 | 2024-08-09 |
| 2024-07-19 | 3443.21 | 未披露 | 定期报告 | 2024-07-16 |
| 2024-08-13 | 3494.34 | 25.00 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - Public Offerings
Issuance of common shares under ESPP
Exercise of warrants
|
2024-06-30 |
| 2024-06-28 | 3494.34 | 25.00 | 定期报告 | 2024-06-27 |
| 2024-06-21 | 3352.28 | 未披露 |
更多>>
Common stock offered 6,130,000 shares by the company
|
2024-06-21 |
| 2024-06-21 | 2739.28 | 未披露 | 定期报告 | 2024-06-18 |
| 2024-05-31 | 2739.03 | 未披露 | 定期报告 | 2024-05-30 |
| 2024-05-15 | 1251.49 | 未披露 | 定期报告 | 2024-05-13 |
| 2024-05-01 | 1166.95 | 未披露 |
更多>>
Common stock offered 1,160,000 shares by the company
|
2024-05-02 |
| 2024-04-29 | 1135.49 | 未披露 | 定期报告 | 2024-04-25 |
| 2024-05-15 | 1039.09 | 25.00 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of common shares - Founders Agreement
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
|
2024-03-31 |
| 2024-03-11 | 1039.01 | 25.00 | 定期报告 | 2024-03-08 |
| 2024-03-11 | 922.03 | 25.00 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common shares - Annual Stock Dividend
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, net of offering costs - Registered Direct Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
Reverse Split (15:1) adjustment
|
2023-12-31 |
| 2023-12-12 | 921.97 | 未披露 | 定期报告 | 2023-12-05 |
| 2023-11-14 | 921.72 | 未披露 | 定期报告 | 2023-11-10 |
| 2023-10-30 | 921.72 | 未披露 |
更多>>
Securities Offered 920,000 shares by the company
|
2023-10-30 |
| 2023-10-30 | 829.72 | 未披露 | 定期报告 | 2023-10-23 |
| 2023-11-14 | 829.64 | 25.00 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares, net of offering costs - At-the-Market Offering
|
2023-09-30 |
| 2023-08-14 | 820.46 | 未披露 | 定期报告 | 2023-08-10 |
| 2023-08-14 | 732.04 | 25.00 | 定期报告 | 2023-06-30 |
| 2023-05-12 | 816.09 | 未披露 | 定期报告 | 2023-05-10 |
| 2023-04-28 | 815.33 | 未披露 | 定期报告 | 2023-04-25 |
| 2023-04-03 | 730.00 | 未披露 |
更多>>
Mustang Bio, Inc. announced that it will effect a 15-for-1 reverse stock split of its issued and outstanding common stock.
|
2023-04-04 |
| 2023-04-03 | 10940.00 | 未披露 | 定期报告 | 2023-04-03 |
| 2023-03-30 | 11024.40 | 未披露 | 定期报告 | 2023-03-27 |
| 2023-03-13 | 11021.98 | 25.00 | 定期报告 | 2023-03-03 |
| 2023-03-30 | 10734.70 | 25.00 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on RWG Debt
Stock-based compensation expenses
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares - Founders Agreement
Issuance of common shares under ESPP
|
2022-12-31 |
| 2022-11-14 | 10730.42 | 未披露 | 定期报告 | 2022-11-11 |
| 2022-11-14 | 10727.32 | 25.00 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2022-09-30 |
| 2022-08-11 | 10606.70 | 未披露 | 定期报告 | 2022-08-09 |
| 2022-08-11 | 10535.66 | 25.00 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Stock-based compensation expenses
|
2022-06-30 |
| 2022-05-12 | 10304.68 | 未披露 | 定期报告 | 2022-05-10 |
| 2022-04-29 | 10247.92 | 25.00 | 定期报告 | 2022-04-25 |
| 2022-05-12 | 10113.32 | 25.00 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares - Equity fee on RWG debt
|
2022-03-31 |
| 2022-03-23 | 10029.08 | 未披露 | 定期报告 | 2022-03-18 |
| 2022-03-23 | 9442.84 | 25.00 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Correction to previously issued shares
Stock-based compensation expenses
Exercise of warrants
Common stock issuable - Founders Agreement
Issuance of common shares - Founders Agreement
|
2021-12-31 |
| 2021-11-12 | 9342.78 | 未披露 | 定期报告 | 2021-11-10 |
| 2021-11-12 | 9200.52 | 25.00 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2021-09-30 |
| 2021-08-16 | 9140.25 | 未披露 | 定期报告 | 2021-08-13 |
| 2021-08-16 | 9078.15 | 25.00 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2021-06-30 |
| 2021-05-14 | 8731.33 | 未披露 | 定期报告 | 2021-05-13 |
| 2021-04-30 | 8654.79 | 未披露 | 定期报告 | 2021-04-20 |
| 2021-05-14 | 8588.85 | 25.00 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
|
2021-03-31 |
| 2021-03-24 | 8517.48 | 未披露 | 定期报告 | 2021-03-23 |
| 2021-03-24 | 7176.61 | 25.00 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Issuance of common shares under ESPP
Exercise of warrants
|
2020-12-31 |
| 2020-11-13 | 6559.35 | 未披露 | 定期报告 | 2020-11-12 |
| 2020-11-06 | 6523.84 | 未披露 | 定期报告 | 2020-11-04 |
| 2020-11-06 | 6100.99 | 25.00 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2020-09-30 |
| 2020-08-10 | 5657.37 | 未披露 | 定期报告 | 2020-08-09 |
| 2020-08-10 | 5567.16 | 25.00 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares, equity fee on Public Offering
Stock-based compensation expenses
|
2020-06-30 |
| 2020-04-29 | 4298.32 | 25.00 | 定期报告 | 2020-04-20 |
| 2020-05-11 | 4292.22 | 25.00 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
|
2020-03-31 |
| 2020-03-16 | 4284.48 | 未披露 | 定期报告 | 2020-03-13 |
| 2020-03-16 | 4024.89 | 25.00 |
更多>>
From December 31, 2018 to December 31, 2019
Conversion of Class A common shares to common shares
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
|
2019-12-31 |
| 2019-11-12 | 4056.35 | 未披露 | 定期报告 | 2019-11-11 |
| 2019-11-12 | 4044.08 | 25.00 |
更多>>
from June 30, 2019 to September 30, 2019
Stock-based compensation expenses
Exercise of warrants
|
2019-09-30 |
| 2019-08-16 | 4047.24 | 25.00 | 定期报告 | 2019-08-15 |
| 2019-08-09 | 4045.04 | 未披露 | 定期报告 | 2019-08-08 |
| 2019-08-09 | 4045.43 | 25.00 |
更多>>
from March 31, 2019 to June 30, 2019
Conversion of Class A common shares to common shares
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
|
2019-06-30 |
| 2019-05-10 | 4025.92 | 未披露 |
更多>>
On April 30, 2019, Mustang announced the pricing of an underwritten public offering, whereby it sold 6,875,000 shares of its common stock, (plus a 30-day option to purchase up to an additional 1,031,250 shares of common stock, which was fully exercised) at a price of $4.00 per share for gross proceeds of approximately $31.6 million.
|
2019-05-09 |
| 2019-05-02 | 3822.89 | 未披露 | 定期报告 | 2019-05-02 |
| 2019-04-30 | 3221.63 | 未披露 | 定期报告 | 2019-04-26 |
| 2019-04-29 | 3215.53 | 未披露 | 定期报告 | 2019-04-23 |
| 2019-05-10 | 2856.14 | 25.00 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Stock-based compensation expenses
Exercise of warrants
|
2019-03-31 |
| 2019-03-18 | 2831.95 | 未披露 | 定期报告 | 2019-03-17 |
| 2019-03-18 | 2761.02 | 25.00 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
|
2018-12-31 |
| 2018-11-13 | 2726.36 | 25.00 |
更多>>
from December 31, 2017 to September 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
|
2018-09-30 |
| 2018-08-13 | 2726.34 | 25.00 |
更多>>
From December 31, 2017 to June 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
|
2018-06-30 |
| 2018-05-14 | 2711.24 | 未披露 | 定期报告 | 2018-05-13 |
| 2018-04-30 | 2710.49 | 未披露 | 定期报告 | 2018-04-16 |
| 2018-05-14 | 2710.16 | 25.00 |
更多>>
from December 31, 2017 to March 31, 2018
Issuance of common shares - Founders Agreement
Exercise of warrants
|
2018-03-31 |
| 2018-03-29 | 2709.66 | 未披露 | 定期报告 | 2018-03-28 |
| 2018-03-29 | 2623.63 | 25.00 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses
Exercise of NSC warrants
|
2017-12-31 |
| 2017-11-14 | 2623.21 | 25.00 |
更多>>
From December 31, 2016 to September 30, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses
|
2017-09-30 |
| 2017-08-22 | 2622.19 | 未披露 | 定期报告 | 2017-08-22 |
| 2017-03-31 | 1616.52 | 25.00 | 定期报告 | 2016-12-31 |
From June 30, 2025 to September 30, 2025
Issuance of common shares, equity fee on At-the-Market and equity offerings
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
From March 31, 2025 to June 30, 2025
Stock-based compensation expenses
Exercise of warrants
From December 31, 2024 to March 31, 2025
Issuance of common shares - Annual Stock Dividend
Issuance of common shares, equity fee on At-the-Market and equity offerings
Issuance of common shares, net of offering costs - Equity Offerings
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Abeyance Shares released
Exercise of warrants
Reverse Split (1-for-50) adjustment
Securities offering 495,000 shares of common stock by the company
a 1-for-50 reverse stock split of its issued and outstanding common stock
From June 30, 2024 to September 30, 2024
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Stock-based compensation expenses
From March 31, 2024 to June 30, 2024
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - Public Offerings
Issuance of common shares under ESPP
Exercise of warrants
Common stock offered 6,130,000 shares by the company
Common stock offered 1,160,000 shares by the company
From December 31, 2023 to March 31, 2024
Issuance of common shares - Founders Agreement
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
From December 31,2022 to December 31,2023
Issuance of common shares - Annual Stock Dividend
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, net of offering costs - Registered Direct Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
Reverse Split (15:1) adjustment
Securities Offered 920,000 shares by the company
From June 30, 2023 to September 30, 2023
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares, net of offering costs - At-the-Market Offering
Mustang Bio, Inc. announced that it will effect a 15-for-1 reverse stock split of its issued and outstanding common stock.
From December 31, 2021 to December 31, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on RWG Debt
Stock-based compensation expenses
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares - Founders Agreement
Issuance of common shares under ESPP
From June 30, 2022 to September 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From March 31, 2022 to June 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Stock-based compensation expenses
From December 31, 2021 to March 31, 2022
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares - Equity fee on RWG debt
From December 31, 2020 to December 31, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Correction to previously issued shares
Stock-based compensation expenses
Exercise of warrants
Common stock issuable - Founders Agreement
Issuance of common shares - Founders Agreement
From June 30, 2021 to September 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From March 31, 2021 to June 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From December 31, 2020 to March 31, 2021
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
from December 31, 2019 to December 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Issuance of common shares under ESPP
Exercise of warrants
From June 30, 2020 to September 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From March 31, 2020 to June 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares, equity fee on Public Offering
Stock-based compensation expenses
From December 31, 2019 to March 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
From December 31, 2018 to December 31, 2019
Conversion of Class A common shares to common shares
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
from June 30, 2019 to September 30, 2019
Stock-based compensation expenses
Exercise of warrants
from March 31, 2019 to June 30, 2019
Conversion of Class A common shares to common shares
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
On April 30, 2019, Mustang announced the pricing of an underwritten public offering, whereby it sold 6,875,000 shares of its common stock, (plus a 30-day option to purchase up to an additional 1,031,250 shares of common stock, which was fully exercised) at a price of $4.00 per share for gross proceeds of approximately $31.6 million.
from December 31, 2018 to March 31, 2019
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Stock-based compensation expenses
Exercise of warrants
from December 31, 2017 to December 31, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
from December 31, 2017 to September 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
From December 31, 2017 to June 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
from December 31, 2017 to March 31, 2018
Issuance of common shares - Founders Agreement
Exercise of warrants
from December 31, 2016 to December 31, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses
Exercise of NSC warrants
From December 31, 2016 to September 30, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses